We are live on ! Find out more
USNA icon

Usana Health Sciences

151 hedge funds and large institutions have $859M invested in Usana Health Sciences in 2017 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 51 increasing their positions, 51 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 15

38% more capital invested

Capital invested by funds: $621M → $859M (+$238M)

5% more funds holding

Funds holding: 144151 (+7)

3.81% more ownership

Funds ownership: 44.55%48.36% (+3.8%)

0% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 51

44% less call options, than puts

Call options by funds: $1.53M | Put options by funds: $2.73M

Holders
151
Holders Change
+7
Holders Change %
+4.86%
% of All Funds
3.42%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
24
Increased
51
Reduced
51
Closed
15
Calls
$1.53M
Puts
$2.73M
Net Calls
-$1.19M
Net Calls Change
-$1.12M
Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$143M +$849K +12,700 +0.7%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$115M -$3.27M -48,826 -3%
Vanguard Group
3
Vanguard Group
Pennsylvania
$76.9M +$1.53M +22,816 +2%
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$56.5M +$776K +11,603 +2%
BlackRock
5
BlackRock
New York
$53.8M +$211K +3,161 +0.4%
Schroder Investment Management Group
6
Schroder Investment Management Group
United Kingdom
$36.7M -$1.18M -17,700 -3%
Norges Bank
7
Norges Bank
Norway
$27.5M -$438K -6,545 -2%
Nordea Investment Management
8
Nordea Investment Management
Sweden
$25.5M -$4.95K -74 -0%
State Street
9
State Street
Massachusetts
$18.7M +$2.32M +34,671 +16%
DZ Bank
10
DZ Bank
Germany
$17.4M +$9.34M +139,643 +146%
JIM
11
Jupiter Investment Management
United Kingdom
$17.3M -$344K -5,137 -2%
TA
12
Teachers Advisors
New York
$15.7M +$168K +2,506 +1%
Northern Trust
13
Northern Trust
Illinois
$12.9M -$205K -3,066 -2%
MCM
14
Matarin Capital Management
New York
$11.2M -$979K -14,642 -9%
Deutsche Bank
15
Deutsche Bank
Germany
$10.6M +$1.28M +19,091 +15%
UBS Group
16
UBS Group
Switzerland
$10.4M -$202K -3,014 -2%
Acadian Asset Management
17
Acadian Asset Management
Massachusetts
$9.77M +$8.38M +125,272 +1,867%
PFC
18
Phocas Financial Corp
California
$9.09M -$348K -5,207 -4%
NI
19
Numeric Investors
Massachusetts
$7.99M +$6.07M +90,800 +531%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$7.93M +$834K +12,468 +13%
Wells Fargo
21
Wells Fargo
California
$7.75M +$2.47M +36,967 +55%
Arrowstreet Capital
22
Arrowstreet Capital
Massachusetts
$7.66M +$4.74M +70,917 +218%
Two Sigma Advisers
23
Two Sigma Advisers
New York
$6.99M -$698K -10,437 -10%
Wellington Management Group
24
Wellington Management Group
Massachusetts
$6.42M +$5.15K +77 +0.1%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$6.23M -$535K -8,005 -9%

USNA Hedge Fund Activity: Q4 2017 in Review

151 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q4 2017, worth a combined $859M — up 38% from $621M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new USNA positions and 15 closed out — a net gain of 9 holders — while 51 added to existing stakes and 51 trimmed.

The largest buyer was DZ Bank, adding an estimated $9.34M. The largest seller was Fidelity Investments, cutting an estimated $3.27M.

  • 151 institutional investors held Usana Health Sciences (USNA) as of Q4 2017, up from 144 in Q3 2017.
  • Funds reported $859M of Usana Health Sciences stock for Q4 2017, up 38% quarter-over-quarter.
  • 24 funds opened new Usana Health Sciences positions in Q4 2017 and 15 closed out, a net change of +9 holders.
  • The largest Usana Health Sciences buyer in Q4 2017 was DZ Bank, an estimated $9.34M added.
  • The largest Usana Health Sciences seller in Q4 2017 was Fidelity Investments, an estimated $3.27M sold.

Based on aggregated 13F filings for Q4 2017.